Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 134,521 | 130,159 | 123,585 | 129,237 | 134,397 |
| Cost of Goods | 104,901 | 103,701 | 99,469 | 106,199 | 106,805 |
| Gross Profit | 29,620 | 26,458 | 24,116 | 23,038 | 27,592 |
| Operating Expenses | 9,593 | 11,868 | 20,168 | 9,063 | 8,594 |
| Operating Income | 20,928 | 15,291 | 4,417 | 14,174 | 19,803 |
| Interest Expense | 2,650 | 2,711 | 2,602 | 2,629 | 3,108 |
| Pre-tax Income | 18,278 | 12,580 | 1,815 | 11,545 | 16,695 |
| Income Tax | 3,754 | 1,911 | 1,746 | 4,076 | 4,691 |
| Net Income Continuous | 14,524 | 10,669 | 69 | 7,469 | 12,004 |
| Minority Interests | 285 | 33 | 223 | 66 | 259 |
| Net Income | $14,239 | $10,636 | $-154 | $7,403 | $11,745 |
| EPS Basic Total Ops | 0.31 | 0.23 | 0.00 | 0.16 | 0.25 |
| EPS Basic Continuous Ops | 0.31 | 0.23 | 0.00 | 0.16 | 0.26 |
| EPS Diluted Total Ops | 0.30 | 0.23 | 0.00 | 0.15 | 0.25 |
| EPS Diluted Continuous Ops | 0.31 | 0.23 | 0.00 | 0.16 | 0.25 |
| EPS Diluted Before Non-Recurring Items | 0.22 | 0.19 | 0.08 | 0.23 | 0.27 |
| EBITDA(a) | $24,522 | $18,961 | $8,134 | $17,838 | $23,479 |